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Three of four patients newly diagnosed with lung cancer have metastatic disease not curable with current therapies. The small percent of patients diagnosed with disease 
limited to the lung are discovered when the cancer lesion is small and asymptomatic. In the 
modern era of high resolution computed tomography (CT) scanning, early cancers may be 
seen as “indeterminate lung nodules”—noncalcified, rounded opacities ranging from 2 to 
30 mm in diameter.1
Small lung nodules, defined as 4 to 8 mm diameter, have variable risk for malignancy 
but are usually too small and inaccessible for successful biopsy.2 Serial imaging is rec-
ommended by the Fleischner Society to ascertain whether growth rates are characteristic 
for malignancy.3 However, scientifically based evidence supporting specific approaches to 
management of lung nodules found incidentally on chest CT is sparse. Most recommenda-
tions have come out of lung cancer screening trials, where asymptomatic volunteers agree 
to adhere to an a priori schedule of serial CT scans.
The National Lung Screening Trial identified indeterminate lung nodules by CT 
among asymptomatic individuals with risk factors for lung cancer.4 The trial, which pro-
vided follow-up imaging combined with community-based diagnostic testing and treat-
ment, resulted in reduced lung cancer death rates among participants screened with chest 
CT compared with those screened with chest radiograph. This result is good news for the 
millions of smokers and prior smokers at risk of lung cancer, because it seems that chest 
CT may be an effective test for early diagnosis. The bad news for the medical care system 
is that approximately 25% to 50% of screenees have at least one indeterminate lung nodule 
greater than 4 mm diameter at baseline screening.4–7 Although the great majority of such 
nodules will not prove to be malignant, follow-up imaging and testing will be needed to 
distinguish benign from malignant nodules.
Thus, we are now fishing for a greater number of early-stage lung cancers in a sea of 
indeterminate small lung nodules. As the technology of imaging advances, knowledge of 
optimal management of lung nodules, and systems to support timely follow-up, must also 
advance.
In this volume of the Journal of Thoracic Oncology, Danforth et al. describe a sophis-
ticated technique to identify individuals with lung nodules on chest CT among members 
of a large health plan (Kaiser Permanente Southern California) operating in a community-
based setting.8 The authors identified lung nodule cases by a computer search of the text 
of chest CT reports from diverse radiology practices. They devised a natural language pro-
cessing algorithm, searching for a set of words and acronyms commonly used by the read-
ing radiologists to describe lung nodules on chest CT scans. Merging this algorithm with 
electronic chart-based procedure and diagnosis codes, the authors report 96% sensitivity 
and 86% specificity in identifying patients with newly recognized lung nodules.
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Fourteen percent of patients with lung nodules were 
subsequently diagnosed with lung cancer across 5.5 years of 
follow-up. The majority were diagnosed within 3 months of 
the report of the lung nodule. This is a much higher incidence 
in rate of lung cancer than reported by the National Lung 
Screening Trial (3.6% over a similar follow-up period). 
However, the difference is not especially surprising because 
Danforth et al. examined a nonvolunteer population of patients 
receiving chest CT scans for nonscreening reasons. More than 
half of the patients had nodules that were 8 mm diameter or 
greater. Many, if not most of the patients, are presumed to 
have had symptoms prompting the CT scans.
Danforth’s algorithm to identify lung nodule findings 
within the text of radiology reports required searching for 
numerous descriptors used by the reading radiologists. If the 
radiologists had followed a standard lexicon, it seems prob-
able that the accuracy of case identification would have been 
greater. From a clinical care perspective, standardizing the 
descriptors has the potential to help clinical providers in nod-
ule management. Ambiguity in description may cause ambi-
guity in management, potentially delaying diagnoses.
A parallel may be drawn with mammography screening 
in the 1980s, when radiologists’ descriptions of breast abnor-
malities were nonstandardized. At that time, recommendations 
for follow-up imaging, diagnostic testing, and surgery were 
often ambiguous.9 In response to the clinical confusion, the 
Breast Imaging Reporting and Data System project (BI-RADS) 
was initiated by the American College of Radiology to stan-
dardize the language descriptors for breast lesions in mammog-
raphy.10 The standardized language, or lexicon, enabled studies 
to predict malignancy from specific types of mammographic 
lesions.11–13 Such studies led, in an iterative manner, to the use of 
increasingly precise language among radiologists. From these 
early efforts, mammography findings were assigned to mutu-
ally exclusive assessment categories (BI-RADS scores), which 
are “decision-oriented.”9 In other words, the categories direct 
the clinician to specific action regarding follow-up manage-
ment. Once in place, the BI-RAD system was recognized as 
an important tool to inform quality assurance and to improve 
patient care.14
Although the algorithm developed by Danforth et al. 
performs reasonably well, natural language processing side-
steps the issue that lung nodule findings within the text of a 
chest CT report should be explicitly stated and standardized. 
As in mammography, the benefits of standardizing a lexicon 
for lung nodules include the following:
1. The radiologist’s impression that a patient has a lung 
nodule suspicious, but indeterminate, for lung cancer 
would be clearly communicated to the ordering clini-
cian. Because most lung nodules are incidental findings, 
clarity of communication is important to ensure timely 
follow-up and management.
2. On the basis of standardized description of a nodule, the 
radiologist could make decision-oriented recommenda-
tions for follow-up surveillance, or diagnostic testing, 
according to best scientific evidence.
3. As in any medical testing where follow-up is critical, a 
systematic method of reminders and call-backs is needed. 
By incorporating evidence-based recommendations for 
follow-up into the text of radiology reports, radiologists 
could provide the information necessary to set up a call-
back registry. Given the rapid growth rate of many lung 
cancers, early diagnosis will depend on the timeliness of 
follow-up imaging and diagnostic testing.15,16
For years clinicians have sought to improve the dismal 
prognosis of lung cancer by diagnosing when the disease is in 
early stage. The National Lung Screening Trial has shown that 
chest CT scanning may provide the best early diagnostic tool 
yet. In order for the imaging technology to realize its promise, 
the accompanying information technology must keep pace. 
In this regard, natural language used by reading radiologists 
should give way to standardized language.
REFERENCES
 1. Swensen SJ, Jett JR, Hartman TE, et al. Lung cancer screening with CT: 
Mayo Clinic experience. Radiology 2003;226:756–761.
 2. Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung 
cancer: suspiciousness of nodules according to size on baseline scans. 
Radiology 2004;231:164–168.
 3. MacMahon H, Austin JH, Gamsu G, et al. Fleischner Society. Guidelines 
for management of small pulmonary nodules detected on CT scans: a 
statement from the Fleischner Society. Radiology 2005;237:395–400.
 4. Aberle DR, Adams AM, Berg CD, et al. National Lung Screening Trial 
Research Team. Reduced lung-cancer mortality with low-dose computed 
tomographic screening. N Engl J Med 2011;365:395–409.
 5. Diederich S, Wormanns D, Semik M, et al. Screening for early lung can-
cer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. 
Radiology 2002;222:773–781.
 6. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer 
Action Project: overall design and findings from baseline screening. 
Lancet 1999;354:99–105.
 7. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with 
low-dose spiral computed tomography. Am J Respir Crit Care Med 
2002;165:508–513.
 8. Danforth KN, Early MI, Ngan S, Kosco AE, Zheng C, Gould MK.  Automated 
Identification of Patients with Pulmonary Nodules in an Integrated Health 
System Using Administrative Health Plan Data, Radiology Reports, and 
Natural language Processing. J Thorac Oncol, 2012;7:1257–1262.
 9. Burnside ES, Sickles EA, Bassett LW, et al. The ACR BI-RADS experi-
ence: learning from history. J Am Coll Radiol 2009;6:851–860.
 10. McLelland R, Hendrick RE, Zinninger MD, Wilcox PA. The American 
College of Radiology Mammography Accreditation Program. AJR Am J 
Roentgenol 1991;157:473–479.
 11. D’Orsi CJ, Getty DJ, Swets JA, Pickett RM, Seltzer SE, McNeil BJ. 
Reading and decision aids for improved accuracy and standardization of 
mammographic diagnosis. Radiology 1992;184:619–622.
 12. Getty DJ, Pickett RM, D’Orsi CJ, Swets JA. Enhanced interpretation of 
diagnostic images. Invest Radiol 1988;23:240–252.
 13. Sickles EA. Periodic mammographic follow-up of probably benign 
lesions: results in 3,184 consecutive cases. Radiology 1991;179: 
463–468.
 14. D’Orsi CJ Kopans DB. The American College of Radiology’s mam-
mography lexicon: barking up the only tree. AJR Am J Roentgenol 
1994;162:595.
 15. Henschke CI, Yankelevitz DF, Yip R, et al.; As the Writing Committee 
for the I-ELCAP Investigators. Lung Cancers Diagnosed at Annual CT 
Screening: Volume Doubling Times. Radiology 2012;263:578–583.
 16. Revel MP, Merlin A, Peyrard S, et al. Software volumetric evaluation of 
doubling times for differentiating benign versus malignant pulmonary 
nodules. AJR Am J Roentgenol 2006;187:135–142.
